A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
Public ClinicalTrials.gov record NCT00457392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Controlled Phase 3, Efficacy And Safety Study Of Sunitinib (SU011248) In Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Treated With Erlotinib
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib alone in patients with advanced/metastatic lung cancer who have received previous treatment with a platinum-based regimen.
Study identification
- NCT ID
- NCT00457392
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 960 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Oct 29, 2013
2007 – 2012
United States locations
- U.S. sites
- 63
- U.S. states
- 24
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Florence | Alabama | 35630 | — |
| Pfizer Investigational Site | Muscle Shoals | Alabama | 35661 | — |
| Pfizer Investigational Site | Scottsdale | Arizona | 85258 | — |
| Pfizer Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Pfizer Investigational Site | Antioch | California | 94531 | — |
| Pfizer Investigational Site | Burbank | California | 91505-4866 | — |
| Pfizer Investigational Site | Downey | California | 90241 | — |
| Pfizer Investigational Site | Fresno | California | 93720 | — |
| Pfizer Investigational Site | La Jolla | California | 92037 | — |
| Pfizer Investigational Site | La Jolla | California | 92093-0987 | — |
| Pfizer Investigational Site | Montebello | California | 90640 | — |
| Pfizer Investigational Site | Pleasant Hill | California | 94523 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Leandro | California | 94578 | — |
| Pfizer Investigational Site | Whittier | California | 90606 | — |
| Pfizer Investigational Site | Fairfield | Connecticut | 06824 | — |
| Pfizer Investigational Site | Brooksville | Florida | 34613 | — |
| Pfizer Investigational Site | Cocoa Beach | Florida | 32931 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Merritt Island | Florida | 32952 | — |
| Pfizer Investigational Site | Rockledge | Florida | 32955 | — |
| Pfizer Investigational Site | Titusville | Florida | 32796 | — |
| Pfizer Investigational Site | Athens | Georgia | 30607 | — |
| Pfizer Investigational Site | Aurora | Illinois | 60504 | — |
| Pfizer Investigational Site | Goshen | Indiana | 46526 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260-2082 | — |
| Pfizer Investigational Site | Council Bluffs | Iowa | 51503 | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| Pfizer Investigational Site | Lafayette | Louisiana | 70503 | — |
| Pfizer Investigational Site | Bethesda | Maryland | 20817 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48106 | — |
| Pfizer Investigational Site | Troy | Michigan | 48085 | — |
| Pfizer Investigational Site | Columbus | Mississippi | 39705 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Tupelo | Mississippi | 38801 | — |
| Pfizer Investigational Site | City of Saint Peters | Missouri | 63376 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68105 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89102 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89106 | — |
| Pfizer Investigational Site | Jamaica | New York | 11432 | — |
| Pfizer Investigational Site | Norman | Oklahoma | 73071 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73102 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73109 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74014 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Lancaster | Pennsylvania | 17605 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77701 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | Grapevine | Texas | 76051 | — |
| Pfizer Investigational Site | Irving | Texas | 75063 | — |
| Pfizer Investigational Site | Bountiful | Utah | 84010 | — |
| Pfizer Investigational Site | Layton | Utah | 84041 | — |
| Pfizer Investigational Site | Murray | Utah | 84157 | — |
| Pfizer Investigational Site | Provo | Utah | 84604 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84102 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84106 | — |
| Pfizer Investigational Site | Sandy City | Utah | 84094 | — |
| Pfizer Investigational Site | West Valley City | Utah | 84102 | — |
| Pfizer Investigational Site | Kennewick | Washington | 99336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00457392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2013 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00457392 live on ClinicalTrials.gov.